Having MS plus depression may be tied to increased risk of death, finds study Hina Zahid7 Sep 2021 2:15 AM GMTMINNEAPOLIS - Depression is common in people with multiple sclerosis (MS), and a new study shows that people with both conditions may be more likely...
Zydus Cadila gets USFDA nod for multiple sclerosis drug Fingolimod Medical Dialogues Bureau25 Jun 2021 7:30 AM GMTFingolimod is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis.
New MRI technique can facilitate disability prediction in multiple sclerosis patients: Study Medha1 May 2021 5:00 AM GMTUK: Advanced MRI techniques can aid in detecting very early changes in the brain of patients with multiple sclerosis (MS) this may lead to more...
Ponesimod bests teriflunomide in lowering relapse rates of multiple sclerosis; JAMA Dr Satabdi Saha9 April 2021 10:45 PM GMTPonesimod was superior to for relapsing multiple sclerosis, in terms of reducing relapse rates, unique active lesions on MRI, and fatigue symptoms,...
FDA allows marketing of Device to Improve Gait in Multiple Sclerosis Patients Hina Zahid30 March 2021 3:26 AM GMTThe U.S. Food and Drug Administration has authorized marketing of a new device indicated for use as a short-term treatment of gait deficit due to mild ...
Siponimod May Improve Thinking Skills in Advanced Multiple Sclerosis: Study Hina Zahid17 Dec 2020 9:15 AM GMTMINNEAPOLIS - Researchers have found in a new study that people with the advanced form of multiple sclerosis (MS) called secondary progressive MS who...
Multiple sclerosis may not increase risk for breast, colorectal cancers: Study Hina Zahid27 Nov 2020 11:00 AM GMTMINNEAPOLIS - People with multiple sclerosis (MS) may not be at higher risk of developing two of the three cancers that occur most commonly in people...
High-dose biotin does not significantly improve multiple sclerosis: Lancet Medha3 Nov 2020 12:28 PM GMTUSA: The use of MD1003, a high-dose of pharmaceutical-grade biotin, did not help in significant improvement of walking speed or disability in patients ...
Beetroot peptide as potential drug candidate for treating inflammatory diseases Hina Zahid1 Nov 2020 11:15 AM GMTIn a recent study, a research group led by Christian Gruber at MedUni Vienna's Institute of Pharmacology isolated a peptide (small protein molecule)...
Zydus Cadila gets USFDA okay for Fingolimod Capsules, Verapamil Hydrochloride Injection ruchika17 Oct 2020 5:46 AM GMTAhmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received final approval from the USFDA to market Fingolimod...
A Simple sugar may promote myelin repair in multiple sclerosis: Study Hina Zahid11 Oct 2020 12:15 PM GMTIrvine, CA- Myelination plays an important role in cognitive development and in demyelinating diseases like multiple sclerosis (MS), where failure of...
Lupin gets USFDA nod to generic equivalent of Tecfidera Delayed-Release Capsules ruchika7 Oct 2020 7:01 AM GMTMumbai, Baltimore: Pharma major, Lupin Limited, has recently announced that the company has received approval for its Dimethyl Fumarate Delayed-Releas...
